peripubertal

The Food and Drug Administration has recommended that health providers consider using alternatives to DEHP-containing medical devices when high-risk procedures are to be performed on male neonates, pregnant women who are carrying male fetuses, and peripubertal males.

Alternatives for significant uses of DEHP in Massachusetts 2008

As just one example, the FDA is concerned enough about the risks of phthalates in medical devices that it recommended the substitution of non-phthalate-containing devices whenever possible, particularly in the care of male neonates, pregnant women who are carrying male fetuses, and peripubertal males. [

Spinwatch 2010